The Linkou Chang Gung Memorial Hospital also known as Chang Gung Memorial Hospital or "Chang Gung Hospital", is a hospital located in Guishan District, Taoyuan City, Taiwan. It is part of the Chang Gung Medical Foundation hospital network.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Chang Gung Memorial Hospital
2
Hoffmann-La Roche
2
Exact Sciences Corporation
1
National Taiwan University Hospital
1
NaviFUS Corporation
1
Taiwan Sunpan Biotechnology Development Co., Ltd.
1
Clinical Trials at Chang Gung Medical Foundation
During the past decade, Chang Gung Medical Foundation conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
2021-09-23
2023-01-06
Recruiting
8
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Chang Gung Medical Foundation" #1 sponsor was "Chang Gung Memorial Hospital" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Exact Sciences Corporation" with 1 trials sponsored, "National Taiwan University Hospital" with 1 trials sponsored and "NaviFUS Corporation"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Chang Gung Medical Foundation"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Virginia Contract Research Organization Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Chang Gung Medical Foundation
According to Clinical.Site data, the most researched conditions in "Chang Gung Medical Foundation" are
"Dementia" (2 trials), "B-cell Lymphoma" (1 trials), "Breast Cancer" (1 trials), "Critical Illness" (1 trials) and "Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Chang Gung Medical Foundation" in a lesser frequency.
Clinical Trials Intervention Types at Chang Gung Medical Foundation
Most popular intervention types in "Chang Gung Medical Foundation" are "Drug" (3 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "Blood Sample Collection" (1 trials), "CHOP" (1 trials) and "Critical Care" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chang Gung Medical Foundation
The vast majority of trials in "Chang Gung Medical Foundation" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Chang Gung Medical Foundation
Currently, there are NaN active trials in "Chang Gung Medical Foundation".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Chang Gung Medical Foundation,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Chang Gung Medical Foundation, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".